SILO PHARMA, INC. Deferred Tax Assets, Capital Loss Carryforwards
SILO PHARMA, INC. (SILO) had Deferred Tax Assets, Capital Loss Carryforwards of $123.93 thousand as of 2020-12-31, per its 10-K/A filed 2021-05-17.
Discontinued › Notes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2021-05-17
- 2020-12-31: Deferred Tax Assets, Capital Loss Carryforwards $123.93K.
- 2019-12-31: Deferred Tax Assets, Capital Loss Carryforwards $123.93K.
- 2018-12-31: Deferred Tax Assets, Capital Loss Carryforwards $206.88K.
- 2017-12-31: Deferred Tax Assets, Capital Loss Carryforwards $179.17K.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards |
|---|---|
| 2020-12-31 | $123.93K 10-K/A · filed 2021-05-17 |
| 2019-12-31 | $123.93K 10-K/A · filed 2021-05-17 |
| 2018-12-31 | $206.88K 10-K · filed 2020-03-20 |
| 2017-12-31 | $179.17K 10-K · filed 2019-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |